Senator Investment Group LP Dexcom Inc Transaction History

Senator Investment Group LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$75.49 - $124.16 $7.55 Million - $12.4 Million	100,000 New	100,000 $12.4 Million
Q2 2022 Aug 15, 2022	SELL	$67.99 - $132.89 $5.1 Million - $9.97 Million	-75,000 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$94.08 - $130.2 $7.06 Million - $9.77 Million	75,000 New	75,000 $38.4 Million
Q1 2021 May 17, 2021	SELL	$84.79 - $104.74 $14.8 Million - $18.3 Million	-175,000 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$78.0 - $104.5 $3.9 Million - $5.23 Million	50,000 Added 40.0%	175,000 $64.7 Million
Q3 2020 Nov 13, 2020	BUY	$95.51 - $112.95 $11.9 Million - $14.1 Million	125,000 New	125,000 $51.5 Million

1,016

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $30.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Senator Investment Group LP, based on Form 13F filings with the SEC.

Stay updated on Senator Investment Group LP with notifications on news.